ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

TCRX TScan Therapeutics Inc

8.56
-0.09 (-1.04%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
TScan Therapeutics Inc TCRX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.09 -1.04% 8.56 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.79 8.55 9.09 8.56 8.65
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202415:05GLOBETScan Therapeutics Announces Upcoming Presentations at the..
24/4/202410:03GLOBETScan Therapeutics Announces Exercise of Underwriters'..
22/4/202416:01GLOBETScan Therapeutics Announces Upcoming Presentations at the..
19/4/202409:05GLOBETScan Therapeutics Announces Closing of Upsized Public..
16/4/202423:30GLOBETScan Therapeutics Announces Pricing of Upsized $150 Million..
16/4/202415:25GLOBETScan Therapeutics Announces Launch of $125 Million Proposed..
16/4/202415:01GLOBETScan Therapeutics Provides Clinical Pipeline Update and..
08/4/202407:00GLOBETScan Therapeutics Appoints Seasoned Hematology and Oncology..
02/4/202406:00GLOBETScan Therapeutics Announces Upcoming Presentation at the..
06/3/202415:11EDGAR2Form S-3 - Registration statement under Securities Act of..
06/3/202415:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202406:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202406:15EDGAR2Form 8-K - Current report
14/2/202415:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202406:15EDGAR2Form 8-K - Current report
11/12/202307:00EDGAR2Form 8-K - Current report
07/12/202306:15EDGAR2Form 8-K - Current report
09/11/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:15EDGAR2Form 8-K - Current report
29/8/202307:02DJNTScan Gets FDA Clearance of Investigational New Drug..
10/8/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:15EDGAR2Form 8-K - Current report
24/7/202318:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202318:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/6/202307:30EDGAR2Form 8-K - Current report
06/6/202309:25DJNTScan Therapeutics Shares Rise 17% After FDA Clears IND for..
25/5/202318:50DJNStocks to Watch: Marvell Technology, Workday, Gap, TScan..
09/5/202309:08DJNTScan Therapeutics Shares Take Flight on Amgen Pact
09/5/202308:48DJNAmgen, TScan Therapeutics Set Crohn's Disease Collaboration

Su Consulta Reciente

Delayed Upgrade Clock